Related Experiment Video
Updated: Dec 13, 2025

Live-imaging of Breast Epithelial Cell Migration After the Transient Depletion of TIP60
Published on: December 7, 2017
TIF1 Proteins in Genome Stability and Cancer
Roisin M McAvera1, Lisa J Crawford1
1Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast BT9 7AE, UK.
The TIF1 family of proteins (TRIM24, TRIM28, TRIM33, TRIM66) are crucial for DNA damage response and genome stability in cancer. Aberrant expression of these chromatin-binding proteins impacts DNA repair, cell cycle, and chromatin regulation.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- Genomic instability, characterized by excessive DNA damage, is a hallmark of cancer.
- The DNA damage response (DDR) is a cellular mechanism that senses and repairs DNA damage, halting cell cycle progression.
- Chromatin-binding proteins are essential for coordinating the DDR within the chromatin context.
Purpose of the Study:
- To review the role of the transcriptional intermediary factor 1 (TIF1) family in cancer.
- To focus on the TIF1 family's functions in DNA repair, chromatin regulation, and cell cycle control.
- To highlight the aberrant expression of TIF1 proteins in various cancer types.
Main Methods:
- Literature review of TIF1 family proteins in cancer.
- Analysis of TIF1 roles in DNA damage response pathways.
- Examination of TIF1 involvement in chromatin modification and cell cycle regulation.
Main Results:
- The TIF1 family (TRIM24, TRIM28, TRIM33, TRIM66) are implicated in maintaining genome stability.
- Aberrant expression of TIF1 proteins is observed across numerous cancer types.
- TIF1 family members mediate chromatin-based responses to DNA damage, influencing repair and cell cycle.
Conclusions:
- The TIF1 family plays a significant role in cancer by regulating DNA damage response and maintaining genome stability.
- Understanding TIF1 functions offers potential therapeutic targets for cancer treatment.
- Further research into TIF1 family's chromatin-binding activities is warranted for cancer therapy development.
More Related Videos
12:19Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
Published on: November 10, 2016
08:34Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...